Chapter 1 — What “Ozempic Face” Really Is

What “Ozempic Face” Really Is (And What It Is Not)

It was November 2022. A fifty-one-year-old woman — let’s call her Karen, the name Dr. Paul Frank later used in some interviews — walked into the doctor’s cosmetic dermatology practice on East 60th Street in Manhattan. She had an appointment for an aesthetic consultation. But not for her body.

Karen had lost forty-six pounds in five months thanks to Ozempic, initially prescribed for diabetes and then continued off-label for weight loss. She was thrilled with the result. But she had a problem: she would look in the mirror and no longer recognize herself. Not because she was thinner. Because she had her mother’s face.

Frank, a celebrity cosmetic dermatologist who had seen thousands of faces, immediately understood what he was looking at. What struck him, however, was not the single case. It was the fact that, in the previous six weeks, he had seen eight patients with exactly the same characteristic. All women between forty-five and sixty. All on a GLP-1. All with a new category of “aesthetic damage” that didn’t fit traditional diagnostic categories.

Frank gave an interview to The New York Times a few weeks later. He coined a term that the journalist transcribed and that the next day began going viral: “Ozempic Face.”

It was the first time anyone had given a name to a phenomenon that thousands of other women were already living, but that until that moment no one had named.

The expression spread at remarkable speed across social media. The hashtag #ozempicface had already passed two million views on TikTok in 2023, and today the cumulative views on the topic are easily in the tens of millions. The term has entered newspapers, conversations, and video headlines. It has generated thousands of articles, dozens of TV segments, a new category of skincare products, and — inevitably — an industry of “solutions,” many of which are bad solutions to a real problem.

And as often happens with viral terms, it has come to be used imprecisely — sometimes exaggerated, sometimes minimized. To build a protocol that works, we first need to be precise about what we are talking about.

The Phenomenon Has Left Hollywood

Between 2024 and 2026 something changed in how the public perceives this problem. It was no longer a concern confined to medical practices in Manhattan or small online patient communities. It had arrived on the red carpet, on prime time, on film sets, on talk show couches.

Open any gossip magazine or scroll through Instagram in the last two years and you’ll find a new subcategory of entertainment journalism: the “celebrities before and after Ozempic” articles. Hollywood actresses who at fifty look seventy. Singers and television hosts unrecognizable from photos taken three years earlier. Politicians who lost forty-five pounds and acquired a hollowed face that fits neither their age nor their strength. Television presenters whose neck, jawline, and temples have become the real story of the show, more than the news they were supposed to deliver.

Tabloids have coined parallel terms to “Ozempic Face”: “Ozempic Neck” for the sagging neck, “Ozempic Hands” for hands that have become bony with visible veins, “Ozempic Body” for the general loss of tone visible on red carpets. Every major gala of 2025 and 2026 — the Oscars, the Met Gala, Cannes — was followed by articles identifying who had maintained a natural appearance and who instead was showing the obvious signs of ultra-rapid weight loss.

The phenomenon has become visually evident everywhere we look. People we knew with a certain face until 2022 now have a different face — and it’s rarely a better face.

This matters for two reasons. First: the problem is real and at enormous scale. It’s not a TikTok exaggeration. It is documented in real time, under spotlights, by professional photographers, in high-resolution photos that thousands of people analyze. Second: even people with unlimited access to plastic surgeons, dermatologists, personal trainers, nutritionists, and essentially unlimited budgets are making the same mistakes as ordinary patients. Not from ignorance, but because the problem is less known and less managed than people think.

If it happened to a major actress with access to the best of the best, it can happen to anyone. The difference isn’t the wallet. It’s knowing what to do before, during, and after therapy.

This book is the operational version of what famous people learned too late.

What It Actually Is

“Ozempic Face” is a colloquial expression, not a medical diagnosis. It describes a set of facial changes that may accompany rapid weight loss, particularly when that loss is induced by GLP-1 medications.

It’s important to distinguish it from adjacent concepts that are often confused with it:

• It is not “accelerated aging” in the biological sense. Your cells are not aging faster. Only the structural appearance of the face is changing.
• It is not generic skin laxity like post-pregnancy. It’s specific to the rapidity of loss and to the facial area.
• It is not “facial muscle atrophy” from natural aging. It’s much faster and has a different anatomical distribution.

The typical changes include seven observable clinical signs. Let’s examine them one by one.

First: Hollow Cheekbones

The cheekbones, which are normally the highlight of the face, lose volume and flatten. What was once a luminous fullness now looks like a fold of skin draped over bone.

Anatomically, this is the emptying of the medial cheek fat compartment and the buccal fat pad (Bichat’s fat pad). When you look at a photo of your face at twenty-five and one of you today after Wegovy, this is the area where your eyes will probably land first.

Visually, you lose the “triangle of youth”: a young face has its wide base at the top (full cheekbones) and narrows toward the bottom (chin). A face that has lost cheekbone volume reverses the triangle: it narrows at the top and widens at the bottom, giving a sagging appearance.

Second: Hollowed Temples

The temples, on either side of the forehead, are normally slightly rounded. In a “deflated” face they become concave, sunken, as if someone had pressed a finger inward.

The temples are anatomically one of the places where fat accumulates least and depletes fastest. It’s also an area where the superficial temporal artery runs very close to the surface. When volume drops, the artery can become visible as a line beneath the skin, and this is one of the most “aging” signals on the face.

Hollowed temples are particularly hard to hide with makeup and impossible to camouflage with a hairstyle change. That’s why it’s the area where many women first notice the problem.

Third: Deeper, Darker Under-Eye Shadows

The fat under the eyes (the infraorbital fat pad) shrinks, and the orbit appears deeper. The shadows under the eyes become more visible, even with adequate rest.

This is not “being tired.” It’s a structural change: the orbital cavity becomes more visible because the fat cushion that filled it has shrunk.

A woman in this situation will often hear “you look tired,” “are you getting enough sleep?”, “everything okay?”. They are well-intentioned comments but confusing for her, because she’s sleeping well, she’s fine, but her face is communicating something else.

Fourth: Less Defined Jawline

The skin of the lower face, once supported by the underlying fat, loses its scaffolding. The jawline becomes less crisp, and in some cases what we call “jowls” appear — a softening at the sides of the mouth.

Interestingly, the starting jawline isn’t the same for everyone. Some people have a naturally very defined mandibular bone structure, and when they lose facial volume their jawline actually becomes more visible (in a positive way, “sculpted”). Others have a less marked structure, and when they lose the fat cushion, what emerges instead is laxity.

Which group are you in? You probably already know, but a quick test: look at yourself in profile in the mirror. If you see a sharp line from ear to chin, you’re in the “sculpted” group. If the line breaks and there’s a small drop at the level of the mouth, you’re in the “laxity” group.

Fifth: Thinner, Less Defined Lip Border

The lips, particularly the upper one, lose a small amount of volume and definition. The “vermilion border” — the sharp edge between lips and skin — becomes less marked.

This is a subtle but very aging change. Young lips have a crisp, defined border. Lips that have lost volume have a blurred, “soft” border that blends into the surrounding skin.

Often accompanied by small wrinkles perpendicular to the upper lip border (the so-called “barcode lines”), which become more visible when the underlying volume decreases.

Sixth: More Pronounced Marionette Lines

The folds running from the corners of the mouth toward the chin — the “marionette lines” — deepen, because they lose the fat “cushion” that used to support them.

These folds are particularly emotionally charged because they’re perceived as a “sad expression” even when the person is happy. It’s very common to hear someone with marked marionette lines say: “Everyone asks me if I’m okay, even when I’m doing great.”

Seventh: Loose Neck

The skin of the neck, losing the support of fatty tissue, can appear softer, with small horizontal folds and a loss of the sharp angle between chin and neck.

The neck is anatomically the area where skin is thinnest in the entire body, and therefore shows underlying volume changes first. It’s also the most sun-damaged area in those who have had significant sun exposure, because many people apply SPF to the face but forget the neck.

The “rebound” of the neck after weight loss is generally slower than that of the face, particularly in people over 50. That’s why it’s one of the first areas where women consider interventions.

Not all seven signs appear in every person. Some people will only develop one or two. Others will develop all seven. The severity depends on multiple factors that we will examine in Chapter 3.

What It Is NOT

Before going further, let’s clear away five myths circulating everywhere.

Myth one: “Ozempic Face” is a disease. False. It is not a pathology, there is no inflammation, there is no permanent tissue damage. It is an aesthetic consequence of rapid loss of facial volume. It does not cause pain, it does not require urgent medical treatment, and it is not progressive if weight loss stabilizes.

Myth two: it only happens with Ozempic. False. It happens with any GLP-1 (semaglutide, tirzepatide, liraglutide), it happens with bariatric surgery, it happens with crash diets, it happens with any significant and rapid weight loss. The drug is an accelerator, not a specific cause. History teaches us that the same phenomenon was well known in bariatric patients long before Ozempic — it just didn’t have a catchy name to trend on TikTok.

Myth three: it is permanent. False, at least in part. A portion of the changes is reversible over time, particularly in younger people with greater skin elasticity, and particularly if you intervene with the right strategies. Even past fifty, the skin retains remodeling capacity if given the time, the nutrients, and the right stimuli.

Myth four: only fillers can fix it. False. Fillers are ONE of the solutions, not the only one. Nutrition, targeted exercises, active skincare, and resistance training can do most of the work, and in many cases make fillers unnecessary or drastically reduce the amount needed. It’s a position aesthetic clinics rarely communicate, for obvious financial reasons.

Myth five: it happens to anyone who takes a GLP-1. False. The probability varies enormously based on age, rate of weight loss, dosage, nutrition, training, and genetics. Many people on GLP-1s develop no significant signs. Others develop them markedly. We will build your personal profile in Chapter 3.

The Scale of the Phenomenon: What the Numbers Say

How frequent is it? How serious?

A 2025 Vanderbilt University study quantified something concrete. The researchers measured the loss of midface volume (the central area of the face, the cheekbone region) in GLP-1 patients through 3D scanning. The result: approximately 9% volume loss for every twenty pounds lost.

Translated practically: a person who loses forty pounds may lose about 18% of their midface volume. A person who loses sixty pounds may lose 27%. These are significant numbers.

For context: 9% of facial volume lost equates, in visual estimation, to a perceptual aging of three to four years. 27% equates to about eight to ten perceptual years. This is why people say “I have my mother’s face” or “I look like my version from ten years ago, but more tired.”

Another key data point comes from a 2023 study in the Journal of Cosmetic Dermatology. Patients who lost more than 2.9 pounds per week had a 65% higher probability of experiencing significant facial volume loss, compared to those who lost weight more gradually. Speed of weight loss is the most important factor.

And then there is the perceptual factor. An observational study found that GLP-1 patients with rapid weight loss can appear up to five years older after therapy. Five years. That is a quantity you notice in the mirror, in photos, in people’s comments.

I am not trying to scare you. I am trying to give you the real numbers, because without numbers you cannot plan well.

Science Box: How Is “Facial Volume” Measured?

When a scientific study talks about “midface volume loss,” how does it actually measure it? There are three main techniques.

3D photographic scanning: the person sits in front of a camera that takes dozens of photos from different angles, and software reconstructs a three-dimensional model of the face. This model is compared months apart to measure volumetric changes in milliliters.

Facial MRI: used in more clinical studies, it allows distinguishing layer by layer (fat, muscle, bone) the variations.

Anthropometric measurement: less technological, uses standardized rulers and calipers to measure specific points on the face. Less precise but more accessible.

The 2025 Vanderbilt study used 3D photographic scanning, considered today the gold standard for studies on outpatients. It’s the same technology some dermatologists use in their practices to document treatment progress, and it’s the technology that will significantly improve in the coming years.

The Case of Sarah: One Story Among Thousands

Let me return to Sarah, the woman I told you about in the introduction. I want to tell you in more detail what happened to her, because it perfectly illustrates the dynamic.

Sarah, forty-seven, started Wegovy in January 2025. She weighed 196 lbs, was 5’5”, with a BMI of 32.7 (Class I obesity). She had tried five times in the past fifteen years to lose weight with traditional dieting, without lasting success.

Her doctor, a competent endocrinologist, had explained the standard drug titration: 0.25 mg for the first four weeks, then 0.5 mg for the next four, then progressively up to 1 mg or 1.7 mg maintenance.

Sarah followed the standard titration. In the first two months she lost 13 lbs. In the third month, going up to 1 mg, she lost another 11 lbs. She was thrilled. People were complimenting her. Old clothes were fitting again.

The doctor told her she could stay on 1 mg for the rest of the treatment, but Sarah — seeing the results — asked to go up to 1.7 mg. The doctor, while emphasizing it wasn’t necessary, agreed.

In months four and five, she lost another 15 lbs. Weight loss speed had gone from about 1.5 lbs/week initially to 2.6-2.9 lbs/week. Total: 40 lbs in five months.

In May, Sarah looked in the mirror and saw what you read in the introduction. Flat cheekbones. Hollow temples. Marked under-eye shadows. Lax neck skin.

The interesting data point? Sarah had done many things right. She was sleeping well. She drank water. She had slightly reduced alcohol. What she hadn’t done was control speed, maintain adequate protein (she ate little because she wasn’t hungry), and start resistance training (she thought weight loss was enough).

Sarah is not an exception. She’s the rule. Most of the women I meet or read about are in a very similar situation. They’ve done well on some fronts, neglected others, and their face has paid the bill.

The good news: Sarah, applying the protocol in this book, recovered significantly in the following twelve months. We’ll talk about it in Chapter 10. For now, what matters is understanding what happened, why it happened, and how to prevent it.

Your First Step: The Photo Self-Assessment

Before going any further, do one concrete thing today.

Take three photos of your face, under these conditions:

• Natural morning light, near a window (not backlit)
• No makeup
• Hair pulled back
• Neutral expression
• Three angles: front, right profile, left profile
• Same distance from face (about 24 inches from camera)
• Same camera height (ideally at eye level)

Save the photos in a folder on your phone dated with today’s date. Set a reminder in your calendar to repeat the process in exactly four weeks, then eight, then twelve.

Why This Step Is Non-Negotiable

Without a baseline, you will never know if what you’re doing works. With a baseline, in three months you will have objective personal data on your own face.

Furthermore, the mirror is deceptive. What you see in the mirror is influenced by your mood at that moment, by the light, by your mental state. The photo is objective. Comparing two photos taken under the same conditions is the most reliable way to measure changes.

Many women find the idea of photos scary. “I don’t want to see myself right now.” “It would depress me.” I understand. But consider that today’s photo is the worst photo you’ll take of your face in the coming months, if you apply the protocol. It’s a starting point, not a judgment.

And a practical tip: don’t look at the photo right after taking it. Save it and forget it for a month. Then compare it with the photo from the next month. You’ll see the differences more clearly, without the “background noise” of your daily perceptions.

Common Mistakes in Self-Assessment

Here are the five most frequent mistakes women make when they start tracking their own face:

Mistake one: using the mirror instead of photos. The mirror changes with light, with angle, with mood. Photos under standardized conditions don’t.

Mistake two: taking photos at different times. The face in the morning is different from the face in the evening. Pick a fixed time slot (ideally morning, after the shower, before makeup).

Mistake three: weighing and photographing at the same moment. They are two different metrics and create cognitive confusion. Weigh on Monday, photograph on Sunday.

Mistake four: comparing with photos from years ago. Your photo at thirty isn’t a valid benchmark for your face at fifty. The benchmark is your photo from a month ago.

Mistake five: asking family or friends for judgment. Close people see you every day and don’t notice gradual changes. Plus, they tend to be reticent so as not to offend. The photo is a neutral judge.

Frequently Asked Questions on This Chapter

How quickly can I notice it’s happening? The first visible signs usually appear between the second and fourth month of GLP-1 therapy, when you’ve lost 18-26 lbs. Before that point, changes are too subtle to be noticed by the naked eye.

My husband/partner tells me I’m exaggerating. How do I know if it’s true? The photos. Close people see you every day and unconsciously adopt “reassurance” strategies. Photos are neutral. Compare photos from six months ago with photos from today. If there are differences, you’ll see them.

Is it worse if I have fair skin? Not significantly. Fair skin can show some shadows earlier (under-eye shadows, hollowed areas), but there isn’t really a genetic predisposition tied to skin color.

Does anything change if I take Mounjaro instead of Ozempic? Tirzepatide (Mounjaro) tends to cause slightly faster weight loss than semaglutide (Ozempic/Wegovy) at maximum dose. So, all else being equal, there’s a slightly higher risk. But speed of weight loss is the main factor, not the specific drug.

What if I’ve already had fillers in the past? Good question. Previous fillers can temporarily “mask” changes, but when they get reabsorbed the face you reveal underneath is the current one, not the one from when you got the filler. Plan accordingly with your aesthetic doctor.

Can I apply this protocol if I’m doing bariatric surgery instead of a GLP-1? Yes, completely. The principles are identical. Rapid weight loss induced by bariatric surgery produces the same facial effects as drug-induced loss, and the protocol works equally well.

What to Take Away from This Chapter

• “Ozempic Face” is a colloquial term describing facial changes from rapid GLP-1-induced weight loss
• The typical clinical signs are seven, and they don’t all appear together: hollow cheekbones, hollowed temples, dark under-eye shadows, lax jawline, thin lip border, marionette lines, loose neck
• Speed of weight loss is the single most important factor (over 2.9 lbs/week = +65% probability of significant facial loss)
• The Vanderbilt study quantifies about 9% midface volumetric loss for every 20 lbs lost
• It is not just an Ozempic issue, it is an issue of any rapid weight loss (including bariatric surgery and crash diets)
• It is not 100% permanent, and it cannot only be fixed with fillers
• Five myths to abandon: it’s not a disease, not just Ozempic, not permanent, not only fillers, not happening to everyone
• Start your photo self-assessment today (front, right profile, left profile, same conditions, every 4 weeks)

In the next chapter we will enter the biology: what exactly happens beneath the skin, and why your face can become the clock that measures the time you have lost.